Sequent Scientific Ltd. | Income Statement
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
4,527
4,362
5,996
8,955
8,478
Cost of Goods Sold (COGS) incl. D&A
4,029
3,957
5,301
7,600
6,177
Gross Income
498
405
695
1,355
2,302
SG&A Expense
529
542
602
968
1,885
Unusual Expense
590
47
62
39
15
Non Operating Income/Expense
69
86
61
68
166
Interest Expense
390
430
381
363
331
Pretax Income
1,099
633
154
6
236
Consolidated Net Income
1,105
667
180
11
102
Net Income
1,105
657
193
62
9
Net Income After Extraordinaries
1,105
1,206
201
14
4,197
Net Income Available to Common
1,105
659
185
138
115
EPS (Basic)
8.55
0.75
0.88
0.58
17.40
Basic Shares Outstanding
129
143
208
239
-
EPS (Diluted)
8.55
0.75
0.89
0.58
-
Diluted Shares Outstanding
129
143
208
239
-
EBITDA
267
142
530
1,010
830
Other Operating Expense
-
28
39
21
-
Non-Operating Interest Income
9
11
32
11
-
Minority Interest Expense
-
10
13
73
93
Preferred Dividends
-
-
-
-
-
About Sequent Scientific
View Profile
